Aflac Incorporated (AFL)

Market Cap	59.80B
Revenue (ttm)	17.70B
Net Income (ttm)	4.17B
Shares Out	524.11M
EPS (ttm)	7.68
PE Ratio	14.86
Forward PE	15.73
Dividend	$2.32 (2.03%)
Ex-Dividend Date	Nov 19, 2025

Volume	2,337,239
Open	114.00
Previous Close	113.70
Day's Range	113.30 - 114.78
52-Week Range	96.95 - 115.43
Beta	0.66
Analysts	Hold
Price Target	110.40 (-3.23%)
Earnings Date	Nov 4, 2025

About AFL

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products t...

• Industry: Insurance - Life
• Sector: Financials
• Founded: 1955
• Employees: 12,694
• Stock Exchange: NYSE
• Ticker Symbol: AFL
• Website: https://www.aflac.com

Financial Performance

In 2024, Aflac's revenue was $18.93 billion, an increase of 1.21% compared to the previous year's $18.70 billion. Earnings were $5.44 billion, an increase of 16.83%.

Analyst Summary

According to 10 analysts, the average rating for AFL stock is "Hold." The 12-month stock price target is $110.4, which is a decrease of -3.23% from the latest price.

Price Target

$110.4

(-3.23% downside)

Analyst Consensus: Hold